Cost-effectiveness of chronic hepatitis C screening and treatment
Hepatitis C virus (HCV) infection is the second most common cause of chronic liver disease in South Korea, with a prevalence ranging from 0.6% to 0.8%, and HCV infection incidence increases with age. The anti-HCV antibody test, which is cheaper than the HCV RNA assay, is widely used to screen for HC...
Main Authors: | Hye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2022-04-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-2021-0193.pdf |
Similar Items
-
Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
by: Chang Hun Lee, et al.
Published: (2023-07-01) -
Costs of Treatment, Follow-Up, and Complications of Chronic Hepatitis B and Hepatitis C Infections
by: Fatma Banu Karahasanoğlu, et al.
Published: (2013-12-01) -
The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection
by: Jin Gu Kang, et al.
Published: (2023-05-01) -
Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis
by: Yuemin Nan, et al.
Published: (2024-02-01) -
Cost-Effective Interventions in The Control of Chronic Hepatitis B (CHB) Infection
by: Mehlika Toy
Published: (2014-05-01)